References
- Kojimahara T, Nakahar K, Takano T, Yaegashi N, Nishiyama H, Fujimori K et al. Yolk sac tumor of the Ovary: A retrospective multicenter study of 33 Japanese women by Tohoku Gynaecologic Cancer Unit (TGCU). Tohoku J Exp Med. 2013;210:211-217.
- Dallenbach P, Bonnefor H, Pelte MF, Vlastos G. Yolk sac tumours of the ovary: an update. Eur J Surg Oncol. 2006;32:1063-1075.
- Guida M, Pignata S, Palumbo A R, Miele G, Marra ML, Visconti F et al. Laparoscopic treatment of a yolk sac tumour: case report and literature review. Translational Med. 2013;7(1):1-5.
- Allmen DV, Fallat ME. Ovarian Tumors. in: O’Neil JA Jr, Rowe MI, Grosfeld JL, Fonkalsrud EW, Coran AG, editors. Pediatric Surgery. 5 th ed. Mosby, New York, USA. 1998. p. 529-548.
- Kang H, Kim TJ, Kim WY, Choi CH, Lee JW, Kim BG, Bae DS. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Gynecol Oncol. 2008;111(1):106-110.
- Fujita M, Inoue M, Tanizawa O, Minagawa j, Yamada T, Tani T. Retrospective review of 41 patients with endodermal sinus tumour of the ovary. Int J Gynaecol Cancer. 3:329-335.
- Tan KengKhoo, Donald P. C. Chan. Embryonal tumour of the ovary with the endodermal sinus pattern. Singapore medical journal –vol 7, N°1, March 1966.
- Moniaga NC, Randall LM. Malignant mixed ovarian germ cell tumour with embryonal component. J Pediatr Adolesc Gynecol. 2011;24(1):e1-e3. doi:10.1016/j.jpag.2010.05.001.
- Nishio S, Ushijima K, Fukui A, et al. Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary. J Obstet Gynaecol Res. 2006;32:416.
- Tewari K, Cappuccini F, Disaia P, et al. Malignant germ cell tumors of the ovary. Obstet Gynecol. 2000;95:128.
- DiSaia, PJ.; Creasman, WT. Germ cell, stromal, and other ovarian tumors. In: Gaertner, R.; Simpson, D., editors. Clinical Gynecologic Oncology. 7. Philadelphia: Mosby Elsevier; 2007:p 369-5.
- Kondagunta GV, Bacik J, Donadio A et al. Combination of paclitaxel, ifosfamide and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J ClinOncol 2005;23(27): 6549-6555.